About the committee
A forum for discussion of issues associated with cannabis products and the associated activities of state regulatory agencies who deal with these products.
Have a question about this committee? Send us a message
Reach out and communicate with other organizations such as AAFCO, AOAC, NEHA, etc., that AFDO now has a cannabis committee and seek opportunities for collaboration and information sharing.
Develop best practices for cannabis production to assist industry and local/state regulators.
Monitor research released about these areas, catalog and disseminate.
Assemble guidance for regulators about the potential for cannabis diversion, including:
a. Identifying the most common steps in the cannabis growing/processing cycles that diversion occurs;
b. Determine ways for regulators to spot diversion and investigate cases;
c. Measures that can help prevent the diversion of cannabis.
Determine the average yield of different cannabis extraction methods, in order to establish what “normal”
yields would be and prevent diversion.
Create guidance for regulators on cannabis business auditing procedures, including:
a. Standard operating procedure (SOP) review and approval process;
c. Track and trace software audits.
Collaborate with the Laboratory, Science & Technology Committee to create a standardized protocol for
homogeneity and stability studies required to be performed on all new cannabis products by state-regulated cannabis
businesses to ensure the safety, consistency, and stability of therapeutic compounds in these products.
One-page summary of FDA’s current legal pathway to develop CBD-containing products, and
understanding how the USDA’s hemp grower regulations relate to businesses who want to manufacture hemp/CBD
products for human consumption.